Successful unconventional precision treatment of inflammatory hormone receptor-positive breast cancer guided by molecular profiling
Abstract We present a unique case of locally advanced, inflammatory hormone receptor (HR) positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer in a young woman. A MammaPrint gene signature performed on the core biopsy indicated a very high risk of recurrence (MammaPrint h...
Saved in:
| Main Authors: | Jailan Elayoubi, Yu Zong, Erich J. Schwartz |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-03-01
|
| Series: | npj Precision Oncology |
| Online Access: | https://doi.org/10.1038/s41698-025-00845-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Molecular classification of hormone receptor-positive /HER2-positive breast cancer reveals potential neoadjuvant therapeutic strategies
by: Chao Liu, et al.
Published: (2025-03-01) -
The untapped potential of radiation and immunotherapy for hormone receptor-positive breast cancer
by: Matthew Fenton, et al.
Published: (2025-07-01) -
Immunotherapy for hormone receptor‒positive HER2-negative breast cancer
by: Fatima Cardoso, et al.
Published: (2024-12-01) -
Multimodal histopathologic models stratify hormone receptor-positive early breast cancer
by: Kevin M. Boehm, et al.
Published: (2025-03-01) -
Combination chemotherapy and hormone therapy in patients with hormone receptor positive and HER2 negative metastatic breast cancer
by: Kripa Bajaj, et al.
Published: (2025-08-01)